Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Amlitelimab for Atopic Dermatitis
Recruiting1 awardPhase 3
Sugarloaf, Pennsylvania
This trial is for people with moderate to severe atopic dermatitis who have not responded well to topical treatments. The purpose of the study is to see if amlitelimab solution, given as
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.